Growth hormone alters lipolysis and hormone-sensitive lipase activity in 3T3-F442A adipocytes by Dietz, James & Schwartz, Jessica
Growth Hormone Alters Lipolysis and Hormone-Sensitive Lipase Activity in 
3T3-F442A Adipocytes 
James Dietz and Jessica Schwartz 
While growth hormone (GH) has long been known as a lipolytic hormone, it has been difficult to study the cellular mechanisms 
for this effect. Since cultured 3T3-F442A adipocytes have recently proven to be useful to study chronic effects of GH on 
adipocyte metabolism, we examined the effects of GH on lipolysis. In these cells, GH alone produced a dose-dependent 
increase in the release of glycerol after 24 to 48 hours. The maximum increase occurred with 10 ng/mL human GH. The effect of 
GH was similar in the presence and absence of dexamethasone. Under each condition, the stimulation of glycerol release was 
accompanied by a GH-induced increase in the activity of hormone-sensitive lipase (HSL), a key lipolytic enzyme. The increase in 
HSL required 24 hours with GH and lasted at least 48 hours. The increase in HSL activity by epinephrine, like glycerol release, 
was potentiated by GH. Although GH potently simulates the activity of the lipogenic enzyme glycerol phosphate dehydroge- 
nase (GPD) in differentiating 3T3-F442A preadipocytes, GH had a negligible effect on GPD activity in the differentiated 
adipocytes with chronic or short-term incubation. However, in contrast to the chronic effect of GH, short-term (30-minute) 
incubation with GH inhibited epinephrine-stimulated glycerol release, a characteristic transient antilipolytic effect of GH. These 
studies indicate that chronic GH treatment is lipolytic in cultured 3T3-F442A adipocytes, and document that lipolytic responses 
to GH involve an increase in the activity of HSL. 
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I T HAS LONG BEEN recognized that growth hormone (GH) treatment decreases carcass lipid.’ Chronic expo- 
sure to GH in vivo has been shown to increase plasma free 
fatty acids, to inhibit the conversion of glucose into lipid, 
and to decrease the lipid content of adipose tissue.’ 
However, the in vitro effects of GH on lipid metabolism, 
particularly on lipolysis, have been controversial. Pituitary 
GH was shown to be lipolytic in isolated adipose tissue or 
adipocytes, but this required the presence of dexametha- 
sone.3,4 Incubation with GH for 1 to 4 hours was subse- 
quently shown to potentiate other lipolytic stimuli in rat 
adipose tissue, such as epinephrine or theophylline,5.b sug- 
gesting that GH modulated other lipolytic stimuli, rather 
than acting as an initiator of lipolysis.' Another challenge to 
the idea that GH was lipolytic was raised by the reported 
failure of highly purified pituitary GH preparations or 
human GH (hGH) of recombinant DNA origin to show 
lipolytic activity,‘.” leading to the suggestion that contami- 
nants in pituitary GH preparations possessed the lipolytic 
activity attributed to GH. However, subsequent studies by 
Goodman and Grichting indicated that these same GH 
preparations were lipolytic in vitro in rat adipose tissue in 
the presence of dexamethasone.““’ Pituitary and biosyn- 
thetic GH also had comparable lipolytic activity in chicken 
adipose tissue.” Moreover, pituitary and biosynthetic GH 
were reported to be lipolytic when administered to hypopi- 
tuitary children,12 attesting not only to the intrinsic lipolytic 
activity of hGH, but also to the importance of this action of 
GH in overall metabolic regulation in humans. 
From the Department of Physiology, Universiq of Michigan Medical 
School, Ann Arbor, MI 48109. 
Supported by National Science Foundation Grant No. DCB 
8609773. J.D. was the recipient of a Student Research Fellowshipfrom 
the lJniversin/ of Michigan. 
Address reprint requests to Jessica Schwartz, PhD. Department of 
Physioloa, Universiy of Michigan Medical School, Ann Arbor. MI 
48109-0622. 
Copyright 0 1991 by WB. Saunders Compaq 
0026-0495191/4008-0006$03.00/O 
800 
With this background of GH as a lipolytic agent, we 
undertook studies to examine the cellular basis for this 
action. As a cellular model, we used cultured 3T3-F442A 
adipocytes. We had found that chronic incubation of these 
cells with GH inhibited various indicators of glucose metab- 
olism, including glucose uptake and conversion to lipid or 
carbon dioxide.” ” The object of the present study was to 
determine first whether chronic incubation with GH also 
affected lipolysis in this adipocyte model, and then to 
evaluate whether changes in the activity of hormone- 
sensitive lipase (HSL) contributed to the observed lipolytic 
responses to chronic GH treatment. Since GH also in- 
creases the activity of glycerol phosphate dehydrogenase 
(GPD), a lipogenic enzyme, in association with promoting 
differentiation of 3T3-F442A preadipocytes to adipocytes. 
we examined the effect of GH on GPD activity in the 
differentiated adipocytes. GH of recombinant DNA origin 
was used throughout to insure that the activity observed was 
intrinsic to the GH molecule. 
MATERIALS AND METHODS 
Materials 
3T3-F442A cells were provided by Dr H Green (Harvard 
University, Cambridge, MA). Sera and media were purchased from 
Irvine Scientific (Santa Ana, CA) or Hyclone (Logan, UT). 
Methionyl hGH (lot K9016AX) was provided by Genentech (South 
San Francisco. CA). Crystalline porcine insulin and dexametha- 
sone were gifts from Eli Lilly (Indianapolis, IN) and Merck 
(Rahway, NJ). respectively. o-[“Cl-glucose (uniformly labeled) 
and [‘JC]-triolein were purchased from New England Nuclear 
(Boston, MA). Fatty acid-poor bovine serum albumin (BSA), 
dihydroxyacetone phosphate. NADH. adenosine triphosphate 
(ATP). and 3-isobutyl-1-methylxanthine were purchased from 
Sigma (St Louis, MO). NAD was purchased from Calbiochem (San 
Diego, CA). GPD and glycerokinase were purchased from Boeh- 
ringer Mannheim Biochemicals (Indianapolis. IN). All other re- 
agents were of the highest grade available. 
Cell Culture 
3T3-F442A cells were grown to confluence in IOO-mm dishes 
(Corning, Corning, NY) in an atmosphere of 10% COI/90% air, 
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using Dulbecco’s modified Eagle’s medium (DMEM) containing 
4.5 g/L glucose and 10% bovine serum. Streptomycin (100 pg/mL), 
penicillin (100 UlmL), fungizone (0.25 &mL), and glutamine (2 
mmol/L) were added to all formulations of DMEM. The confluent 
cells were converted to adipocytes in the presence of 10% fetal 
bovine serum, dexamethasone (0.25 pmol/L), insulin (2 &mL) 
and 3-isobutyl-1-methyl-xanthine (0.5 mmol/L) for 48 hours. The 
cells were then maintained in DMEM with 10% fetal bovine serum 
until 70% to 80% conversion was achieved. Before experimenta- 
tion, the cells were deprived of serum for 18 to 24 hours by 
incubation with DMEM (1 g/L glucose) containing 2% BSA. 
Lipolysis 
Lipolysis was measured as the release of glycerol into the 
incubation medium.” Adipocyte monolayers were incubated in 4.0 
mL of Krebs-Ringer bicarbonate buffer (pH 7.4) with 4% BSA, 1 
mmol/L glucose, and hormones or vehicle. Preliminary experi- 
ments indicated that the increase in glycerol release due to 
epinephrine, and cell viability, were greater in cells incubated with 
1 mmol/L glucose than in cells incubated without glucose. At 
specified times, the incubation medium was removed and assayed 
for glycerol concentration by the method of Weiland.18 The cells 
were washed with phosphate-buffered saline (PBS), scraped with a 
rubber policeman into 1N NaOH and assayed for protein content. 
Glycerol output is expressed as pmol glycerol released per mg 
protein. 
Hormone-Sensitive Lipase 
After incubation with and without hGH and other hormones, 
adipocyte monolayers were scraped in 250 FL of 200 mmol/L 
MOPS with 10 mmol/l_ MgCl, and homogenized by 10 passages 
through a 25-gauge needle. Assays optimized for HSL activity” 
were performed on total homogenate, since preliminary experi- 
ments in which pellet and supernatant were assayed separately 
indicated no major difference in lipase activity or in hormone 
response in the fractionated material as compared with homoge- 
nate. This difference from previous reports may reflect methodolog- 
ical differences related to using monolayers as opposed to sus- 
pended cells.“‘~“” The lipase assay was performed in a total volume 
of 200 FL, containing 50 mmol/L sodium phosphate (pH 7.0), 2.8% 
BSA, 150 mmol/L emulsified triolein, and 120 FL of cell homoge- 
nate. [‘YZ]-triolein was emulsified with unlabeled triolein” to 
provide 2,500 cpm/nmol triolein. After a l-hour incubation at 37°C 
cleaved fatty acids were extracted by the addition of 1.0 mL of a 
mixture of chloroform-methanol-benzene (2:2.4:1) containing 50 
pg/mL carrier oleic acid, followed by 67 uL of 0.5N NaOH. 
Samples were vortexed vigorously for 20 seconds, and centrifuged 
at 1,000 x g for 5 minutes to separate the lower organic layer and 
the upper aqueous layer containing extracted fatty acids. An 
aliquot of the upper layer was removed, suspended in ACS 
(Amersham) scintillation cocktail and radioactivity was measured 
by liquid scintillation counting. Remaining cell homogenate was 
assayed for protein content by the method of Lowry et al.*’ Enzyme 
activity is expressed as U/mg protein. One unit of enzyme activity 
corresponds to the release of 1 nmol oleic acid per hour. The assay 
conditions used are optimal for HSL and are relatively incompati- 
ble with assays for lipoprotein lipase,22 another lipase present in 
cultured adipocytes. 
Lipid Accumulation 
Monolayers of 3T3-F442A adipocytes were incubated at 37°C in 
DMEM (1 g/L glucose) with 1% BSA, D-['4C]-ghICOSe (0.1 t&i/ 
mL), and hormones or vehicle as indicated for 48 hours. The 
reaction was terminated by removal of the incubation medium and 
scraping of cells in Dole’s reagent (isopropyl alcohol:heptane:lN 
H,SO,; 40:10:1).23 The lipids were extracted, the amount of lipid 
was determined gravimetrically, and radioactivity of the lipids was 
measured. Incorporation of glucose into lipid was expressed as cpm 
per mg of lipid. 
Glycerol Phosphate Dehydrogenase 
Monolayers of 3T3-F442A adipocytes were incubated with or 
without hormones for specified lengths of time. Cells were washed 
three times with PBS and scraped with a rubber policeman into 0.5 
mL of 50 mmol/L Tris buffer (pH 7.5) with 1 mmol/L EDTA and 1 
mmol/L p-mercaptoethanol. Cell suspensions were disrupted on 
ice for 5 seconds at 80% maximum output with the microtip of a 
Branson (Danbury, CT) model 350 Sonifier. Samples were centri- 
fuged for 20 minutes at 30,000 x g at 4°C. Fat cakes were removed 
and the infranatants were stored at -70°C. Assays for GPD used a 
modificatior? of the method of Kozak and Jensen.*’ Briefly, assays 
were performed in a total volume of 1 mL, containing 100 mmol/L 
triethanolamine. 2.5 mmol/L EDTA, 0.12 mmol/L NADH, 0.1 
mmol/L p-mercaptoethanol, 0.2 mmol/L dihydroxyacetone-phos- 
phate, and 0.25 mL of infranatant containing solubilized enzyme. 
The change in absorbance was followed at 340 nm on a Beckman 
model 24 spectrophotometer (Fullerton, CA). Infranatant protein 
concentration was determined by the method of Lowry et al.” 
Enzyme activity is expressed as U/mg protein. One unit of enzyme 
activity corresponds to the oxidation of 1 nmol NADH per minute. 
Statistics 
Values are shown as mean 2 SE. Data expressed as percent of 
maximum refer to the percent of the maximum increment pro- 
duced by the hormone(s) in that experiment. Data were analyzed 
by Student’s t test when two values were compared, and by 
ANOVA for repeated measures (StatView 512) followed by 
Scheffe F test when multiple comparisons were made. A value of P 
< .05 was considered significant. 
RESULTS 
GH Stimulates Lipolysis 
To determine whether GH increased lipolysis in cultured 
murine 3T3-F442A adipocytes, glycerol release was mea- 
sured after a 48-hour incubation with hGH of recombinant 
DNA origin. GH at 1 to 100 ng/mL significantly increased 
glycerol release (Fig IA). This lipolytic response was 
dose-dependent, reaching a maximum at 10 ng/mL. The 
extent of the increase, approximately 40%, corresponds 
well with the extent of the increase observed with GH in 
adipose tissue and in human subjects.‘0~13 
Because dexamethasone has been shown to potentiate 
the lipolytic effect of GH in rat adipose tissue and adipo- 
cytesy the effect of GH was also examined in the presence 
of this glucocorticoid. Dexamethasone alone significantly 
increased glycerol release (Fig 1A). However, the increase 
in glycerol release with increasing concentrations of GH 
was similar in the presence and absence of dexamethasone. 
The similarity is especially evident when the responses are 
expressed as percent of the maximum increment produced 
by the hormones, as shown in Fig 1B. 
GH Stimulates HSL 
HSL is a major control point in the lipolytic pathway in 
adipocytes.‘6,‘7 To determine if stimulation of HSL plays a 
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Fig 1. GH stimulates lipolysis in the presence and absence of dexamethasone after a 48-hour incubation. (A) comparison of the effect of GH on 
glycerol release in the absence and presence of dexamethasone. Each point represents the mean t SE of quadruplicate observations in a 
representative experiment. In the absence of dexamethasone, GH at concentrations of 1 ng/mL and higher produced significant (P < ,011 
increases in glycerol release. In the presence of 41 nmol/L dexamethasone, GH at concentrations of 2, 10, and 100 ng/mL produced significant 
(P < .05) increases over dexamethasone alone. (B) Each point represents the mean + SE of 12 observations in three different experiments. Alone, 
GH significantly (P < ,001) increased glycerol release at all concentrations tested from 1 ng/mL and higher. In the presence of dexamethasone, GH 
increased (P < ,001) glycerol release at concentrations of 10 ng/mL and higher. 
role in the lipolytic response to GH in the 3T3-F442A 
adipocytes, cells were incubated with and without GH (50 
ng/mL) for 24 hours and assayed for HSL activity. Under 
these conditions, GH increased HSL activity, from 31 ? 0.5 
to 39 I 0.6 U/mg protein (P < ,005) in a representative 
experiment. The effect of GH on HSL activity was dose- 
dependent (Fig 2). An increase in lipase activity was 
evident with 1 ng/mL hGH, and continued to increase with 
increasing GH concentrations to 100 ng/mL of GH 
(P < .OOl). A highly reproducible increase of similar mag- 
nitude was observed in every experiment, averaging 19% ? 
2% (n = 6) above control values. Figure 3 shows the 
comparison in HSL activity at various times over a 48-hour 
period in adipocytes incubated in the presence and absence 
of GH. For the first 20 hours, there was no consistent 
difference in lipase activity between GH-treated and con- 
trol cells, although lipase activity increased gradually in 
both groups. By 24 hours, lipase activity was significantly 
greater in GH-treated cells than in controls. The increase 
due to GH was maintained for at least 24 hours longer. The 
elevation at the 48-hour time point reflects the fact that GH 
treatment prevented a decrease in lipase activity observed 
in the controls. 
GH is known to potentiate the lipolytic response to other 
hormones such as epinephrine.‘.“’ To determine whether 
the potentiation reflected regulation at the level of HSL, 
3T3-F442A adipocytes were incubated with GH for 23 
hours, and then were challenged with epinephrine (1 
ngimL) for a final hour. The effectiveness of epinephrine in 
stimulating HSL activity was increased significantly in the 
cells previously incubated with GH (Fig 4). Thus, potentia- 
tion by GH is evident in the activity of HSL, as well as in 
glycerol release. 
GPD Activity 
GPD activity is markedly increased by GH in differenti- 
ating 3T3-F442A prcadipocytes, and is often used as a 
marker for GH-induced differentiation.‘“-Z” Since GPD is a 
lipogenic enzyme, it was of interest to determine whether 
GH altered the activity of GPD in the differentiated 
adipocytes, and if so, whether such changes corresponded 
to the effects of GH on incorporation of “C-glucose into 
lipid (lipid accumulation).‘4.” This might show whether 
decreased lipogenesis, as well as increased lipolysis, contrib- 
uted to the inhibition of lipid incorporation due to chronic 
GH treatment in these cells. Changes in GPD activity did 
not correspond to changes in lipid accumulation (Table 1). 
After 48 hours, when GH inhibited lipid accumulation, GH 
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Fig 2. GH stimulates the activity of hormone-sensitive lipase after 
24-hour incubation. Each point represents the mean + SE of quadrupli- 
cate observations in a representative experiment. The response to GH 
is significant (P < 0.001) at 100 ng/mL. Similar results were obtained 
in five other experiments. 
increased GPD activity. In the same experiment, insulin 
increased both the incorporation of glucose into lipid and 
GPD activity after 48 hours (not shown). Thus, although 
GPD is susceptible to hormonal regulation in the 3T3- 
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Fig 3. Time course of the increase in HSL activity due to GH. The 
increment due to GH (50 ng/mL) is shown as percent above the 
control at each time point, and was significant at 24 (P < 0.01). 36 
(P < .05), and 48 (P < 901) hours. The initial value for lipase activity 
was 13.1 + 0.81 U/mg protein. Each point represents the mean f SE 
for three to four observations in a representative experiment. Similar 




Fig 4. GH potentiates epinephrine-stimulated HSL activity after 24 
hours. The increment in lipase activity due to epinephrine (1 ng/mL) is 
shown. Cells incubated with (W) or without (0) GH (50 ng/mL) for 23 
hours. During the final hour, the response to epinephrine was mea- 
sured. Control values were 32.2 f 1.0 in the absence of GH, and 39.8 + 
1.5 U/mg protein in the presence of GH (P < .005). 
F442A adipocytes, its regulation by GH does not appear to 
contribute in a major way to the GH-induced decrease in 
the incorporation of glucose into lipid. This is consistent 
with our recent observations that in the cultured adipo- 
cytes, GH does not alter the expression or transcription of 
the gene for GPD (G. Gurland et al, unpublished observa- 
tions). 
Short- Term Responses to GH 
A hallmark of GH action in adipocytes is that short-term 
responses (eg, 30-minute) are characteristically opposite to 
the delayed responses (eg, after several hours). In GH- 
deficient preparations, the delayed responses to GH, which 
are insulin-antagonistic, are typically preceded by transient 
insulin-like responses.L6 One example of such a response is 
inhibition by GH of epinephrine-stimulated lipolysis in 
adipocytes from hypophysectomized rats.2.6.3’“3 Figure 5 
shows that in the 3T3-F442A adipocytes, GH inhibited 
epinephrine-stimulated lipolysis. Comparing Figs 4 and 5 
indicates that the inhibition of epinephrine-stimulated 
lipolysis is transient, since after 24 hours, GH potentiated 
epinephrine-stimulated glycerol release and HSL activity. 
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Table 1. Noncorrespondence of GH-induced Changes in Lipid Accumulation and GPD Activity 
.___- 
Lipid Accumulation GPD Actwfy 
(cpmimg lipid) (Uimg protefni 
Incubation Time Control GH C0ntr0l GH 
48-hour 23,064 k 604 17,136 k 302 24.8 2 0.3 28.0 i 0.8 
Percent change due to GH 26% decrease 13% increase 
4.hour 3,242 2 138 4,619 i 260 35.8 k 2.6 30.8 z 1.0 
Percent change due to GH 50% increase 14% decrease 
NOTE. Lipid accumulation is expressed as the incorporation of “C-glucose into lipid. GPD activity is evaluated as the oxidation of NADH. Values are 
presented as means + SE of quadruplicate observations in a representative experiment. After 48 hours, GH (1 FgimL) produced a significant 
(P < .Ol) decrease in lipid accumulation and increase (P < .05) in GPD activity. After 4 hours, GH produced a significant (P i .05) increase in lipid 
accumulation, and had no significant effect on GPD activity. Similar observations were made in two other experiments. 
Another insulin-like response evident after short-term 
incubation with GH is increased, rather than decreased, 
lipid accumulation (Table 1). However, GH had a negligi- 
ble or even slightly inhibitory effect on GPD in the same 
cells. This indicates that GPD, which is so sensitive to GH 
in the preadipocytes in association with differentiation, 
does not contribute substantially to modulation of lipid 






Fig 5. GH inhibits epinephrine-stimulated lipolysis with 30 min- 
utes incubation. The increase in glycerol release due to epinephrine is 
shown. Each bar represents the mean k SE of quadruplicate observa- 
tions in a representative experiment. Epinephrina, 1 ng/mL, increased 
glycerol release from a control value of .88 to 1.08 pmol/mg protein in 
this experiment. This was designated maximal lipolysis and corre- 
sponds to 100% (designated control). When epinephrine and GH (500 
ng/mL) were added simultaneously (m), GH reduced the change in 
glycerol release by 45%. The decrease was statistically significant 
(P < .Ol). Similar observations were made in three other experi- 
ments. 
DISCUSSION 
GH Is Lipolvtic and Stimulates the Activity of HSL With 
Chronic Incubation 
Recombinant DNA-derived hGH was lipolytic after long- 
term incubation, in that it stimulated glycerol release in the 
3T3-F442A adipocytes. This is significant since it has been 
reported that highly purified hGH lacked lipolytic activity 
in closely related 3T3-Ll cells.jJ Differences in handling of 
the cells (eg, duration of incubation, prior serum depriva- 
tion period, glucose concentration in the medium), and 
possibly in the GH preparation used, may account for this 
discrepancy. Since the recombinant DNA-derived hGH is 
necessarily free of pituitary contaminants, the present 
findings are in agreement with other reports that stimula- 
tion of lipolysis is intrinsic to the GH molecule.“” The 
magnitude of the response observed is characteristically 
modest,“’ in keeping with observations of 40% stimulation 
of glycerol release by biosynthetic GH in rat adipose 
tissue,“‘,” m chicken adipose tissue” and in human sub- 
jects.” It should be noted that the inhibition of lipolysis by 
adenosine. which potently antagonizes GH-stimulated lipol- 
ysis,ih was unchecked in these experiments, which were 
performed in the absence of adenosine deaminase. If this 
enzyme were present. the effect of GH would be expected 
to be greater, as observed for other hormones. ii 
It is of note that GH alone was lipolytic in the cultured 
adipocytes. This contrasts with the requirement for dexa- 
methasone in rat adipocytes to detect lipolytic activity of 
GH,” and underscores the fact that GH has direct lipolytic 
activity. The reason for the difference in interaction bc- 
tween GH and dexamethasone in the two types of adipo- 
cytes is not clear, especially since GH potcntiated the 
lipolytic effect of epinephrine or theophylline in the 3T3- 
F442A adipocytes, consistent with observations in rat adipo- 
cytes.’ 5 
These studies further indicate that the GH-induced 
increase in lipolysis is due, at least in part, to stimulation of 
the activity of HSL when GH is added to cultured adipo- 
cytes. The involvement of HSL is also evident in the 
potentiation by GH of epinephrine-stimulated lipolysis. 
HSL, which plays a key role in hormone-regulated lipolysis, 
is activated by phosphoxylation stemming from a cyclic 
adenosine monophosphate (CAMP)-mediated event.“‘.‘” In 
fact, the antilipolytic effect of GH in noradrenaline- 
GH STIMULATES LIPOLYSIS AND HSL IN CULTURED ADIPOCYTES 
stimulated rat adipocytes is associated with dephosphoryla- 
tion of HSL.39 With prolonged incubation, GH may increase 
the activity of HSL by favoring the phosphorylation of the 
enzyme, although this has not been demonstrated. In 
addition, the lag period required for detecting the stimula- 
tion of HSL by GH in 3T3-F442A adipocytes suggests that 
synthesis of the enzyme, possibly induction of the gene for 
HSL,40,4’ may be involved. 
GPD Is Insensitive to GH in 3T3-F4424 Adipocytes 
In differentiated 3T3-F442A adipocytes, GPD activity 
was relatively insensitive to GH, particularly as compared 
with preadipocytes. Changes in GPD activity thus do not 
correspond to, and do not appear to contribute substan- 
tially to, the changes in lipid accumulation produced by GH 
in 3T3-F442A adipocytes. The lack of effect of GH on GPD 
may be related to the relatively high levels of GPD activity 
in differentiated 3T3-F442A adipocytes, as compared with 
the preadipocytes. Hence, subtle modulation of GPD by 
GH might be obscured by high basal levels in the adipo- 
cytes, while regulation by GH is evident in the preadipo- 
cytes, which have low basal levels of GPD activity. This is in 
marked contrast to sensitivity of GPD to GH in the 
preadipocytes, in which this enzyme is used as a marker of 
differentiation, since its activity increases as much as 
2,000-fold with GH-induced differentiation and its synthe- 
sis and expression of its mRNA increase similarly.z7-29~42~43 
While GPD appears to be insensitive to GH in the 
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adipocytes, other lipogenic enzymes, for example those 
involved in fatty acid synthesis (fatty acid synthetase, malic 
enzyme, ATP citrate lyase, acetyl CoA carboxylase, pyru- 
vate carboxylase) may be modulated by GH. All of these 
enzymes, except pyruvate carboxylase, have been reported 
to be inhibited by GH in hepatocytes or rat adipocytes.44,45 
Like GPD, they have all been observed to increase with 
differentiation of 3T3-F442A or the closely related 3T3-Ll 
adipocytes,45-48 suggesting that they might be regulated by a 
differentiation-promoting agent such as GH. However, 
activities of the various lipogenic enzymes can be regulated 
independently of each other.4’ Furthermore, changes in 
lipogenic enzymes do not have to be invoked to account for 
GH-dependent changes in lipid accumulation in these cells, 
since GH-induced changes in glucose transport may be 
sufficient to account for these responses to GH in the 
3T3-F442A adipocytes.‘6 
In conclusion, using an in vitro model for studying 
chronic metabolic effects of GH, which appear to be 
representative of its in vivo physiological actions, we have 
examined cellular mechanisms for effects of GH on lipid 
metabolism. Our findings indicate that GH alone is lipolytic 
in 3T3-F442A adipocytes, and that changes in the activity of 
HSL contribute to its lipolytic activity. GPD is not substan- 
tially regulated by GH in the differentiated cells, although 
this lipogenic enzyme is highly sensitive to GH in 3T3- 
F442A preadipocytes. It will be of great interest to pursue 
mechanisms for these direct effects of GH at the molecular 
level. 
REFERENCES 
1. Lee MO, Schaffer HK: Anterior pituitary growth hormone 
and the composition of growth. J Nutr 7:337-363,1934 
2. Goodman HM, Schwartz J: Growth hormone and lipid 
metabolism, in Knobil E, Sawyer W (eds): Handbook of Physiol- 
ogy, set 7, vol 4, pt 2. Washington, DC, American Physiological 
Society, 1974, pp 211-231 
3. Goodman HM: Multiple effects of growth hormone on 
lipolysis. Endocrinology 83:300-308, 1968 
4. Fain JN, Kovacev VP, Scow RO: Effect of growth hormone 
and dexamethasone on lipolysis and metabolism in isolated fat cells 
of the rat. J Biol Chem 240:3522-3529,1965 
5. Goodman HM: Effects of growth hormone on the lipolytic 
response of adipose tissue to theophylline. Endocrinology 82:1027- 
1034,196s 
6. Goodman HM: Effects of growth hormone on isolated adi- 
pose tissue, in Pecile A, Muller E (eds): Growth Hormone. New 
York, NY, Elsevier, 1968, pp 153-171 
7. Frigeri LG: Absence of in vitro dexamethasone-dependent 
lipolytic activity from highly purified growth hormone. Endocrinol- 
ogy 107:738-743,198O 
8. Frigeri LG. Robe1 G, Stebbing N: Bacteria-derived human 
growth hormone lacks lipolytic activity in rat adipose tissue. 
Biochem Biophys Res Commun 104:1041-1046,1982 
9. Bowden CR, White KD, Lewis UJ, et al: Highly purified 
human growth hormone fails to stimulate lipolysis in rabbit 
adipocytes in vitro or in rabbits in vivo. Metabolism 4:237-243,1985 
10. Goodman HM, Grichting G: Growth hormone and lipolysis: 
A reevaluation. Endocrinology 113:1697-1702,1983 
11. Goodman HM: Biological activity of bacterial derived hu- 
man growth hormone in adipose tissue of hypophysectomized rats. 
Endocrinology 114:131-135,1984 
12. Campbell RM, Scanes CG: Lipolytic activity of purified 
pituitary and bacterially derived growth hormone on chicken 
adipose tissue in vitro. Proc Sot Exp Biol Med 180:513-517,1985 
13. Van Vliet G, Bosson D, Craen M, et al: Comparative study 
of the lipolytic potencies of pituitary-derived and biosynthetic 
human growth hormone in hypopituitary children. J Clin Endo- 
crinol Metab 65:876-879,1987 
14. Schwartz J: Growth hormone directly alters glucose utiliza- 
tion in 3T3 adipocytes. Biochem Biophys Res Commun 125:237- 
243,1984 
15. Schwartz J, Foster CM: Pituitary and recombinant DNA- 
derived growth hormones alter glucose metabolism in 3T3-F442A 
adipocytes. J Clin Endocrinol Metab 62:791-794, 1986 
16. Schwartz J, Carter-Su C: Effects of growth hormone on glu- 
cose metabolism and glucose transport in 3T3-F442A cells: Depen- 
dence on cell differentiation. Endocrinology 122:2247-2256,1988 
17. Vaughan M: The production and release of glycerol by 
adipose tissue incubation in vitro. J Biol Chem 237:3354-3359,1962 
18. Weiland 0: Glycerol-UV method, in Bergmeyer H (ed): 
Methods in Enzymatic Analysis (~013). San Diego, CA, Academic, 
1962, pp 1404-1409 
19. Hirsch AH, Rosen OM: Lipolytic stimulation modulates the 
subcellular distribution of hormone-sensitive lipase in 3T3-Ll 
cells. J Lipid Res 25:665-677,1984 
20. Khoo JC, Kawamura M, Jensen DF, et al: Development of 
hormone-sensitive lipase in differentiating 3T3-Ll cells: activation 
and phosphorylation by CAMP-dependent protein kinase. Cold 
Spring Harbor Conf Cell Prolif 8:675-685,198l 
606 DIET2 AND SCHWARTZ 
21. Lowry OH, Rosebrough NJ, Farr AL, et al: Protein estima- 
tion with Folin-Ciocalteau reagent. J Biol Chem 193:265-275, 19.51 
22. Cryer A: Comparative biochemistry and physiology of lipopro- 
tein lipase, in Borensztajn J (ed): Lipoprotein Lipase. Chicago, IL, 
Evener, 1987, pp 282-283 
23. Dole V, Meinertz J: Microdetermination of long-chain fatty 
acids in plasma and tissues. J Biol Chem 235:2595-2599, 1960 
24. Pairault J. Green H: A study of the adipose conversion of 
suspended 3T3 cells by using glycerophosphate dehydrogenase as 
differentiation marker. Proc Nat1 Acad Sci USA 76:5138-5142, 
1979 
25. Kozak LP, Jensen JT: Genetic and developmental control of 
multiple forms of L-glycerol 3-phosphate dehydrogenase. J Biol 
Chem 249:7775-7781.1974 
26. Belfrage P, Fredrikson G, Olsson H, et al: Regulation of 
adipose tissue lipolysis through reversible phosphorylation of 
hormone-sensitive lipase. Adv Cyclic Nucl Prot Phosphorylation 
Res 17:351-359, 1984 
27. Yeaman SJ: Hormone-sensitive lipase-A multipurpose en- 
zyme in lipid metabolism. Biochim Biophys Acta 1052:128-132. 
1990 
28. Morikawa M, Nixon T, Green H: Growth hormone and the 
adipose conversion of 3T3 cells. Cell 29:783-789. 1982 
29. Nixon TB. Green H: Contribution of growth hormone to the 
adipogenic activity of serum. Endocrinology 114:527-532, 1984 
30. Doglio A, Dani C. Grimaldi P, et al: Growth hormone 
regulation of the expression of differentiation-dependent genes in 
preadipocyte Ob1771 cells. Biochem J 238:123-129. 1986 
31. Goodman HM: Antilipolytic effects of growth hormone. 
Metabolism 19:849-855,197O 
32. Birnbaum RS. Goodman HM: Studies on the mechanism of 
the antilipolytic effect of growth hormone. Endocrinology 99:1336- 
1345,1976 
33. Goodman HM, Coiro V: Induction of sensitivity to insulin- 
like action of growth hormone in normal rat adipose tissue. 
Endocrinology 108:113-119, 1981 
34. Frigeri LG, Khoo JC, Robe1 G: Absence of lipolytic activity 
from purified human growth hormone in cultured 3T3-Ll adipo- 
cytes. Hormone Res 17:197-201,1983 
35. Davidson MB: Effect of growth hormone on carbohydrate 
and lipid metabolism. Endocrine Rev 8:115-131, 1987 
36. Sengupta K. Long KJ, Allen DO: Growth hormone stimula- 
tion of lipolysis and cyclic AMP levels in perifused fat cells. J 
Pharmacol Exp Therapeut 217:15-19, 1981 
37. Smith U. Kuroda M. Simpson IA: Counter-regulation of 
insulin-stimulated glucose transport by catecholamines in the 
isolated rat adipose cell. J Biol Chem 259:8758-8763, 1984 
38. Stralfors P. Belfrage P: Phosphorylation of hormone- 
sensitive lipase by cyclic-AMP dependent protein kinase. J Biol 
Chem. 258:15146-15152. 1983 
39. Bjorgell P. Rosberg S, Isaksson 0. et al: The antilipolytic, 
insulin-like effect of growth hormone is caused by a net decrease of 
hormone-sensitive lipase phosphorylation. Endocrinology I 15:1151- 
1156, 19X4 
10, Holm C. Kerchgessner TG. Svenson KL. et al: tlormone- 
sensitive lipase: Sequence. expression and chromosomal localiza- 
tion to 19 cent-q13.3. Science 241:1503-1506, 198X 
41. Holm C, Kerchgessner TG. Svenson KL, et al: Nucleotide 
sequence of rat adipose hormone sensitive lipase cDNA. Nucleic 
Acids Res 16:9879. 1988 
42. Wise LS, Green H: Participation of one isozyme ot cystolic 
glycerophosphate dehydrogenase in the adipose conversion of 3T3 
cells. J Biol Chem 254273.275. 1979 
43. Spiegelman BM, Frank M, Green H: Molecular cloning of 
mRNA from 3T3 adipocytes. Regulation of mRNA content for 
glycerophosphate dehydrogenase and other differentiation-depen- 
dent proteins during adipocyte development. J Biol Chem 258: 
10083- 10089. 19X3 
44. Schaffer WT: Effects of growth hormone on lipogenic 
enzyme activities in cultured rat hepatocytes. Am I Physiol 
248:E719-E725. 1985 
45. Bornstein J. Ng FM, Heng D. et al: Metabolic actions of 
pituitary growth hormone. I. Inhibition of acetyl-CoA-carboxylase 
by human growth hormone and a carboxyl terminal part sequence 
acting through a second messenger. Acta Endocrinol (Copenh) 
103:479-4X2, 1983 
46. Mackall JC. Student AK, Polakis SE, et al: Induction ot 
lipogenesis during differentiation in a “preadipocyte” cell line. J 
Biol Chem 25 116462-6464, 1976 
47. Kuri-Harcuch W, Green H: Increasing activity of enzymes 
on pathway of triacylglycerol synthesis during adipose conversion 
of 3T3 cells. J Biol Chem 252:7158-2160. 1977 
4X. Angus CW, Lane MD: Increase in translatable mRNA for 
mitochondrial pyruvate carboxylase during differentiation of 3T3 
preadipocytes. Biochem Biophys Res Commun 11)3:3216-1222. 
1981 
49. Spiegelman BM. Green H: Cyclic AMP-mediated control of 
lipogenic enzyme synthesis during adipose differentiation of 3T3 
cells. Cell 24:503-510. 1981 
